Skip to content

Epidural anesthesia with ropivacaine and its effects in the duration of the muscular relaxation produced by rocuronium.

Epidural Adminstration of ropivacaine and its effects on the pharmacodynamics of rocuronium: randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7cyp6t
Enrollment
Unknown
Registered
2018-08-17
Start date
2015-03-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural Anesthesia

Interventions

In group 1 (epidural combined with general anesthesia, n = 30), with the patients in a seated position, epidural block was performed with 18G Tuohy needle after local anesthesia provided with 60 mg of
(ii) propofol (2.0 to 2.5 mg.kg-1) followed by rocuronium (0.6 mg.kg-1) for intubation, injected within 5 seconds. The patients were ventilated under mask with 100% oxygen, until the maneuvers of lary
Drug
Device
Procedure/surgery

Sponsors

Faculdade de Ciências Médicas - Universidade Estadual de Campinas
Lead Sponsor
Faculdade de Ciências Médicas - Universidade Estadual de Campinas
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Elective Abdominal Surgeries performed under general anesthesia with or without association of epidural analgesia; female sex; age between 18 and 65 years old. Use of neuromuscular blocking agents; physical state ASA 1 and 2.

Exclusion criteria

Exclusion criteria: neuromuscular, renal and hepatic diseases; BMI greater than 32.5 or less than 20.0 kg.m-2; hydroelectrolytic and acid-base disorders; use of drugs that interact with neuromuscular blockers; contraindication to spinal blocks; history of hypersensitivity to drugs used

Design outcomes

Primary

MeasureTime frame
Predicted outcome: A 20% time extension for recovery of a T4 / T1 ratio of 90% TOF = 0.9, assessed by monitoring neuromuscular block through peripheral nerve stimulator and thumb accelerometer measurement continuously evaluated throughout the operation, only after the intervention.; Outcome found: there was no prolongation in time for recovery of a T4 / T1 ratio of 90% TOF = 0.9.

Secondary

MeasureTime frame
Predicted outcome: A 20% time extension for the clinical duration, assessed by monitoring neuromuscular block through peripheral nerve stimulator and thumb accelerometer measurement continuously evaluated throughout the operation, only after the intervention.;Outcome found: there was no prolongation in clinical duration.

Countries

Brazil

Contacts

Public ContactFernando Eduardo Junqueira

Faculdade de Ciências Médicas - Universidade Estadual de Campinas

feresjunqueira@gmail.com+5511988645808

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 19, 2026